A detailed history of Nemes Rush Group LLC transactions in Embecta Corp. stock. As of the latest transaction made, Nemes Rush Group LLC holds 16 shares of EMBC stock, worth $221. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 16 -0.0%
Holding current value
$221
Previous $200,000 6.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$10.13 - $14.6 $121 - $175
-12 Reduced 42.86%
16 $200,000
Q3 2023

Nov 09, 2023

SELL
$15.0 - $22.17 $105 - $155
-7 Reduced 20.0%
28 $422,000
Q2 2023

Aug 02, 2023

BUY
$21.6 - $30.69 $756 - $1,074
35 New
35 $756,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $799M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.